 | Up a level |
2016
Hoster, E., Geisler, C. H., Doorduijn, J., van der Holt, B., Walewski, J., Bloehdorn, J., Ribrag, V., Salles, G., Hallek, M., Pott, C., Szymczyk, M., Kolstad, A., Laurell, A., Raty, R., Jerkeman, M., van't Veer, M., Kluin-Nelemans, J. C., Klapper, W., Unterhalt, M., Dreyling, M. and Hermine, O. (2016). Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. Leukemia, 30 (6). S. 1428 - 1431. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Walewski, J., Hellmann, A., Siritanaratkul, N., Ozsan, G. H., Ozcan, M., Chuncharunee, S., Goh, A. S., Jurczak, W., Koren, J., Wang, B., Singh, S., Huebner, D. and Engert, A. (2016). SINGLE-ARM STUDY OF BRENTUXIMAB VEDOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA WHO ARE INELIGIBLE FOR STEM CELL TRANSPLANTATION OR MULTIAGENT CHEMOTHERAPY. Haematologica, 101. S. 56 - 57. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078